We share your mission to develop life-changing cell and gene therapies. Accelerate commercialization with end-to-end solutions that deliver reproducible performance and scalability with a simplified path to regulatory approvals.
From discovery, to process development, to clinical and commercial manufacturing, our portfolio of proven solutions helps you achieve faster time-to-market while saving costs. Together, we're setting the standard in cell and gene therapy.
Consult Our Experts Request Your Sample
Setting the Standard in Reproducible PerformanceA high-performing process lays the foundation for reproducible results. Accelerate your cell and gene therapy development with high-throughput technologies that promote process efficiency, optimized critical raw materials that improve yield, and intuitive data analytics that inform decision-making.
Setting the Standard in Streamlined Scale-UpDesigned with scalability in mind, our range of cell culture bioreactors, single-use bags, media, and reagents enable seamless process transfer to larger volumes. Streamline revalidation and optimization from the start by leveraging decades of demonstrated expertise in scalable upstream and downstream solutions.
Setting the Standard for a Simplified Path to Regulatory ComplianceIn a rapidly changing landscape, adhering to the latest regulatory requirements is critical to simplifying your registrations and interactions with authorities. Meet efficacy and safety standards with products and services backed by rigorous quality-assurance processes and trusted to deliver approved therapeutics worldwide.
Support each step of MSC, iPSC, and HSC workflows from discovery to commercialization.
Accelerate your AAV workflow with robust, scalable, and high-quality consumables, technologies, and services.
Simplify the route of your cell therapy from discovery, to development, and on to manufacturing.
Browse technologies, analytics, and services that support your gene therapy toward commercialization.
Ready to set the standard in cell and gene therapy with Sartorius? Watch our teaser video to see how we’re helping to make the impossible possible — with our innovative technologies, expert support, and more.
Read about the challenges of liquid handling in CGT processes, and how new solutions can simplify aliquoting.
Expert Talk: How do single-use systems affect therapeutic cells?
Learn how high-quality raw materials simplify the journey of cardiomyocyte therapies from lab to clinical trials.
Enhance your cell culture media strategy for protein, viral, and cell-based production processes.
See how the differences between CGT and traditional biopharmaceutical manufacturing are giving rise to new risk assessment challenges.
Discover methods for growing and enhancing CAR-T cells in automated stirred-bioreactors.
Reach therapeutic doses of CAR-T cell therapy with scalable expansion processes.
Control virus risk in cell culture media for viral vector and gene therapy.
Learn how to mitigate cell culture variability with robust screening of raw materials and adhere to GMP guidelines.
Browse our featured products below to find solutions that shorten your time-to-market and improve cost-efficiency at every step of your workflow.
Increase AAV titer and particle quality with optimized transfection reagents and plasmids.
Increase processing speed and recovery with scalable, single-use, and low-shear centrifugation systems for cell harvest and washing.
Manage your entire cold chain with confidence – from filling and freezing to shipping, thawing, and dispensing.
Stabilize your cell and gene therapy product with versatile recombinant human albumin.
Remove turbidity, increase AAV yield, and scale up easily with high-capacity and low-adsorption filters.
Preserve sterility during connection and disconnection throughout your biomanufacturing process.
Achieve higher viability and yield from 200 to 2,000 liters with geometrically consistent bioreactor vessels.
Increase viral vector recovery using low adsorption membranes with MWCO ranging 30 to 300kDa, available in closed, presterilized units.
Protect your product during storage and shipping for sterile filtration, media preparation, sampling, and fluid transfer steps.
To help find the right materials and consumables for your needs, request a sample from our portfolio.
Request Your Sample
Learn more about cell and gene therapy news and events.
July 18, 2023 - Sartorius completes acquisition of Polyplus
September 19, 2023 - Sartorius establishes a competence center for manufacturing components for cell and gene therapies in Freiburg
September 28, 2023 - Sartorius forms partnership with SPARTA Biodiscovery on novel nanoparticle analysis platform
September 30, 2022 - Sartorius completes acquisition of Albumedix
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.